Key result
Preoperative versus postoperative dalteparin initiation shows no difference in coagulation or fibrinolysis activation in THA.
Why the study?
Does initiating 5000 IU dalteparin subcutaneously 12 hours before surgery improve plasma coagulation and fibrinolysis biomarkers compared to 6 hours after surgery in patients undergoing cemented total hip arthroplasty?
RCT (n=20)
Double-blind
Randomized strata
No
Does initiating 5000 IU dalteparin subcutaneously 12 hours before surgery improve plasma coagulation and fibrinolysis biomarkers compared to 6 hours after surgery in patients undergoing cemented total hip arthroplasty?
Activation of coagulation and fibrinolysis by operative trauma in total hip arthroplasty is similar whether dalteparin prophylaxis is initiated 12 hours before or 6 hours after surgery.
Answers are grounded in this paper and cite their sources.
Dalteparin timing does not alter post-THA coagulation activation; confirms equivalent biomarker effects for pre- versus post-operative initiation.
Venous thrombosis is common in elective hip surgery, and prophylaxis is recommended. Clinical trials suggest that the drug dose and timing of initiating prophylaxis significantly influence antithrombotic effectiveness and safety. We studied the time course and gradient of plasma coagulation and fibrinolysis during total hip arthroplasty (THA) in twenty patients that were randomly assigned to have the first dose of 5000 IU dalteparin subcutaneously (sc) injected 12 hours before or 6 hours after surgery. Baseline characteristics were similar in both groups. Specific biomarkers on coagulation (prothrombin fragment 1+2 (F1+2)) and fibrinolytic activity (plasmin/ α 2-antiplasmin complex (PAP) and D-dimer) were collected at six events during hospitalization and analysed. There were no significant group differences in the biomarkers at any time point. The highest concentrations were measured 6 hours after surgery and before the first postoperative injection. A marked decrease followed at the first postoperative day, and then a second increase in plasma concentrations was observed 6 days after surgery. This study showed that activation of coagulation and fibrinolysis by the operative trauma was the same when the first dose of dalteparin was injected 12 hours before or 6 hours after surgery.
No takes yet. Share an insight, caveat, or question.
Borgen et al. (2013) conducted an RCT in Total Hip Arthroplasty (THA) (n=20). Dalteparin 12 hours before surgery vs. Dalteparin 6 hours after surgery was evaluated on Plasma coagulation and fibrinolysis biomarkers (F1+2, PAP, D-dimer) (p=ns). Initiating 5000 IU dalteparin 12 hours before versus 6 hours after total hip arthroplasty resulted in no significant differences in the activation of coagulation and fibrinolysis biomarkers.
Synapse has enriched 10 related papers. Consider them for comparative context: